|
⚲
|
| Juvaris Bio Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001347758 |
| Sale | 2009-09-11 ($25.1 M Offered, $15.1 M Sold) |
| Fund | |
| Phone | 6506978828 |
| Address | 866 Malcolm Road, Suite 100 Burlingame, 94010 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kimberlee Gonzaga | |
| Michael Ross | |
| Thomas Monath | |
| Grant Pickering | |
| Lewis Williams | |
| Carol Brosgart |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Activant Ventures III Opportunities Fund 5, LP
✚
|
0.0 | |
|
Activation Venture Fund, LP - A3
✚
|
0.0 | |
|
Activation Venture Fund, LP - A4
✚
|
0.0 | |
|
ActiveClass, Inc.
✚
|
0.0 | |
|
Activity Rocket, LLC
✚
|
0.0 | |
|
ActivOrtho, Inc.
✚
|
0.0 | |
|
Chan Patty
✚
|
0.0 | |
|
Gavito Mauricio Gomez-Mont
✚
|
0.0 | |
|
Gavito Miguel Gomez-Mont
✚
|
0.0 | |
|
Gatemore Capital Management LLP
✚
|
0.0 |